Drug treatment for spinal muscular atrophy type I

Wendy M J Bosboom, L. H. Van Den Berg, S. T. Iannaccone, A. F J E Vrancken, J. H J Wokke

Research output: Contribution to journalReview article

5 Scopus citations

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows: To review systematically the evidence from randomised controlled trials concerning the efficacy and safety of any drug therapy designed to slow or arrest the progress of the disease in SMA type I. We will perform a separate Cochrane review on SMA type II and III.

Original languageEnglish (US)
Article numberCD006281
JournalCochrane Database of Systematic Reviews
Issue number4
DOIs
StatePublished - Dec 1 2006

ASJC Scopus subject areas

  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'Drug treatment for spinal muscular atrophy type I'. Together they form a unique fingerprint.

  • Cite this

    Bosboom, W. M. J., Van Den Berg, L. H., Iannaccone, S. T., Vrancken, A. F. J. E., & Wokke, J. H. J. (2006). Drug treatment for spinal muscular atrophy type I. Cochrane Database of Systematic Reviews, (4), [CD006281]. https://doi.org/10.1002/14651858.CD006281